Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
45.25
+3.12 (7.41%)
Jun 25, 2026, 3:52 PM EDT - Market open
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $4.94 billion as of June 25, 2026. Its market cap has increased by 727.91% in one year.
Market Cap
4.94B
Enterprise Value
4.63B
1-Year Change
727.91%
Ranking
Category
Stock Price
$45.25
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $4.94B, an increase of 728.95%. That is a compound annual growth rate of 39.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 4.94B | 274.16% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 5.32B |
| Caris Life Sciences | 5.23B |
| CRISPR Therapeutics AG | 5.22B |
| Oruka Therapeutics | 5.03B |
| Dianthus Therapeutics | 4.98B |
| Veradermics | 4.78B |
| Celcuity | 4.69B |
| Erasca | 4.62B |